For example, BRX-0585, a transferrin-glucagon-like peptide-1 (GLP-1) fusion protein for the treatment of type 2 diabetes mellitus (T2DM), demonstrated significantly enhanced half-life. This evidence concerns the gene GCG and type 2 diabetes mellitus.